1 Outcome of the 4 th Global Animal Health Conference (GAHC) 24 -25 June 2015 Bettye K. Walters, DVM US Food and Drug Administration

Slides:



Advertisements
Similar presentations
UNITED NATIONS’ RESPONSE TO THE
Advertisements

ENTITIES FOR A UN SYSTEM EVALUATION FRAMEWORK 17th MEETING OF SENIOR FELLOWSHIP OFFICERS OF THE UNITED NATIONS SYSTEM AND HOST COUNTRY AGENCIES BY DAVIDE.
SANITARY AND PHYTOSANITARY HARMONIZATION
Capacity building to support strengthening of veterinary legislation Donor country perspective – Australia Dr Joffrid Mackett Consul (Agriculture) - Middle.
1 African ICT Roadmap to Achieve NEPAD Objectives Arusha, Tanzania, 1-3 April 2003 Roles of Government and ATU in the Implementation of NEPAD ICT objectives.
The Effectiveness of Global Health Partnerships Findings and Lessons from a World Bank Evaluation of Global Health Programs Uma Lele April 14, 2005.
1 Standards and Trade Development Facility (STDF) Melvin Spreij Mobilizing Aid for Trade for SPS-related technical cooperation in East Africa Overview.
Singapore February 2001 Promoting Fair and Transparent Regulation in Securities Markets A Presentation to the APEC-OECD Co-operative Initiative on Regulatory.
1 Trade facilitation: Benefits and Capacity Building for Customs UNECE International Forum on Trade Facilitation, May 2003 Kunio Mikuriya Deputy.
Supporting National e-Health Roadmaps WHO-ITU-WB joint effort WSIS C7 e-Health Facilitation Meeting 13 th May 2010 Hani Eskandar ICT Applications, ITU.
4 th Kitasato-Harvard Symposium: Summary and Conclusions Stephen Lagakos Harvard School of Public Health.
1 Coordinating and Financing R&D in Developing Countries-moving beyond PDP's The ANDI Experience Solomon Nwaka CEWG on R&D Financing & Coordination, April.
Merton V. Smith, Ph.D., J.D. Director International Programs Center for Veterinary Medicine U.S. Food and Drug Administration Governance of Veterinary.
Steven D. Vaughn, DVM Director Office of New Animal Drug Evaluation Center for Veterinary Medicine U. S. Food and Drug Administration June 6, 2012 Embracing.
Breakout Session English I. Impact of Poor Coordination No notifications to the WTO Outdated information on NEP & NNA Lack of consistency of national.
International Standards for Food Quality and Safety – Accomplishments of the Codex Alimentarius Commission International Symposium on Food Safety Standards.
Regulatory Body MODIFIED Day 8 – Lecture 3.
ICH-GCG June 2009 Pan American Health Organization CURRENT STATUS OF PAN AMERICAN NETWORK FOR DRUG REGULATORY HARMONIZATION (PANDRH): James Fitzgerald.
Session 3 - Plenary on implementing Principle 1 on an Explicit Policy on Regulatory Quality, Principle 3 on Regulatory Oversight, and Principle 6 on Reviewing.
Executive summary prepared by some members of the ICH Q9 EWG for example only; not an official policy/guidance July 2006, slide 1 ICH Q9 QUALITY RISK MANAGEMENT.
Departmental Perspectives on Viral Hepatitis
Sustaining Change in Higher Education J. Douglas Toma Associate Professor Institute of Higher Education University of Georgia May 28, 2004.
The International Task Force on Harmonization and Equivalency in Organic Agriculture (ITF)
Public –Private Partnership as a means to Improve Animal Welfare Globally Dr Ann Wilkinson, President, SSAFE Food SafetyAnimal HealthPlant Health Food.
11 Workshop on Establishment of a Continental Accreditation Agency for Higher Education in Africa 10 – 11 April 2013, Addis Ababa Rationale for Establishing.
Page 1 | Confidential and Proprietary Information Unearthing the Power of PAOs Around the World Amarjit Chopra Deputy Chair IFAC PAO Development Committee.
And Pharmaceuticals Health Technology Technical Cooperation for Essential Drugs and Traditional Medicine Challenges of Medicine Regulation in Africa Global.
Development with Disabled Network Mainstreaming Disability into Community Governance System Asitha Weweldeniya, Weweldenige, Development with Disabled.
Protocol on Water and Health Realistic Targets – Achievable Action Plans 5 th World Water Conference, Istanbul Senior Adviser Carola Bjørklund.
Moving Forward With the African Dialogue Cross-Border Principles By Mary Gurure Manager, Legal Services and Compliance COMESA Competition Commission Lilongwe,
Ggim.un.org. The United Nations initiative on Global Geospatial Information Management A formal mechanism under UN protocol to discuss, enhance and coordinate.
Introduction Research indicates benefits to companies who establish effective worker safety and health programs: –Reduction in the extent and severity.
LEVELS OF HEALTH CARE VINITA VANDANA.
SUMMARY OF DISCUSSIONS AMONG AFRICAN SITES PRIOR TO THE WORLD BANK'S VIDEO- CONFERENCE: “OPEN STANDARDS FOR GOVERNMENT TRANSFORMATION” 17TH APRIL 2009.
Peter B. Bloland, DVM, MPVM Director Division of Public Health Systems and Workforce Development Global Health Leadership Forum November 10, 2011 National.
Organization and Implementation of a National Regulatory Program for the Control of Radiation Sources Regulatory Authority.
Challenges to Organic Trade Organic Standards and Technical Regulations 70 countries with organic regulations of some type Some standards only Some,
Legal Aspects of GHS Implementation Compiled by Goh Choo Ta.
1/28/2016 Prevention Research and Natioanl Aids Plans Geneva 1 Prevention Research and National AIDS Plans June 2005 Geneva, Switzerland Prof. Roy.
WHO Regional Workshop on Good Manufacturing Practices for Blood Establishments Dr Ana Padilla, Blood Products & related Biologicals Essential Medicines.
2005 Europe/US International Aviation Safety Conference, Cologne 7-9 June The Europe-US International Aviation Safety Conference 2005 ‘ Aviation Safety.
Gas Regional Initiative Impact of the 3rd package & creation of RIG Benoît Esnault (CRE), GRI TF co-chair NW GRI – RCC and ministerial meeting Paris, 8.
3rd WHO Prequalification Stakeholders Meeting :Diagnostics 3rd Stakeholders Meeting on Prequalification Geneva, 4th February 2008 Update on Prequalification.
Overcoming challenges in pediatric oncology product development: Regulatory oversight of multi-national clinical studies Ursula Kern, Advisory Committees.
Ministerial Declaration and Concluding Remarks MD PhD Karin Tegmark Wisell Chair AMR expert group, NDPHS.
VICH General Principles and current update of VICH Outreach Forum activity 1.
VICH Training Strategy Steven D. Vaughn, DVM Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine U.S. Food and Drug Administration.
Introduction to the VICH Outreach Forum Steven D. Vaughn, DVM VICH Workshop Dar Es Salaam, Tanzania – June 24, 2015.
Medical Device Regulations in Canada; Key Challenges and International Initiatives.
Industry: trends, concerns hopes and ideas VICH5 Conference Carel du Marchie Sarvaas, Executive Director October 2015.
-What is VICH, History and Objectives Hervé MARION, DVM VICH Secretariat.
1 VICH AND VETERINARY MEDICINES AVAILABILITY VICH5 CONFERENCE, OCTOBER 2015, TOKYO VICH AND VETERINARY MEDICINES AVAILABILITY VICH5 CONFERENCE, OCTOBER.
2010 James Fitzgerald Senior Advisor, Medicines and Health Technologies PAHO/WHO rd St Washington DC USA International Cooperation in Quality.
Health Technology Assessment Methodology, an EUnetHTA View Basics for the Assessment in EU Countries PharmDr. Martin Visnansky, MBA, PhD., MSc. (HTA) HTA.
Supporting measurement & improvement of primary health care (PHC) at the facility and community levels Dr. Jennifer Adams, Deputy Assistant Administrator,
The Benefits of VICH to VICH Member Countries and Regions DONALD A. PRATER, DVM Director, U.S. FDA Europe Office Office of International Programs Office.
Session 9: The Vision for the Future 1 Dr. Yuko Endo JMAFF.
How to get involved in VICH Dr. Allen Bryce Independent consultant Canberra, Australia VICH Workshop: Dar Es Salaam, Tanzania – 24.
1 The contribution of VICH to the global One Health approach VICH5 CONFERENCE, OCTOBER 2015, TOKYO Jean-Pierre Orand, Anses, France, OIE Collaborating.
VICH General Principles and
Technical Assistance and Capacity Building Activities in SADC
Human Resources Competency Framework
Declaration of the 11th ministerial-level PAC meeting in Berlin 2015 From strategies to action – how to tackle the challenges of Antimicrobial Resistance.
How Can I Get More Information on VICH?
The role of the OIE in biological threat reduction
Dr Manisha Shridhar Regional Advisor WHO-SEARO
SRO APPROACH TO REGULATION
An Enabling Business Environment and A Strategic Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,
An Enabling Business Environment and A Strategy and Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,
Presentation transcript:

1 Outcome of the 4 th Global Animal Health Conference (GAHC) June 2015 Bettye K. Walters, DVM US Food and Drug Administration :

2 4 th Global Animal Health Conference (GAHC) June 2015 Dar Es Salaam, Tanzania 101 attendees from 36 countries 100% had their expectations met 96% rated the GAHC as excellent – good 98% rated the GAHC as informative and comprehensive GAHC presentations can be found at 2

3 Guiding Principles human health Harmonization is important because it also impacts food security and human health. Core set of scientific competencies that can lead to the availability of safe, effective and quality veterinary medical products –Reduced animal mortality, disease diagnosis, prevention, and treatment –Increased animal health and production leads to more food production –Increased food production to keep pace with growing population

4 Conference Objectives and Sessions Promote market control Improve market access Promote mutual recognition and the formation of regional organizations Implement African regional harmonization initiatives and discuss local opportunities and challenges towards the implementation of harmonized regulatory systems

5 Session 1: Why is Regulatory Convergence important and what can it facilitate? Regulatory convergence can: expand drug and vaccine development and marketing eliminate obstacles to trade increase access to therapies and vaccines for emerging diseases (60% of which are zoonotic) provide greater certainty in the regulatory process reduce the number animals needed for testing lend greater legitimacy to regulatory decisions 5

6 Session 1: What is needed for Regulatory Convergence to work? Commitment at political and senior management level Shared language Facilities and human resources required for coordination Recognition of the work of other international bodies such as OIE, Codex, VICH, WHO Recognition that convergence of pre- authorisation activities is only one element of an authorization and control system for VMPs

7 Session 2: Market Control EXAMPLE: Malaysia Comprehensive regulatory system in Malaysia that evolved from collaboration through ASEAN The system is complex and has many facets to be comprehensive. The system evolved and is kept current by regular discussion in ASEAN. Need for benchmarking the competencies of regulatory authorities with the aim of building mutual trust

8 Session 2: Market Control EXAMPLE: PANVAC Arose out of the lessons learned from Rinderpest Established a regional laboratory with testing, market controls and training for personnel in other laboratories, manufacturers, and regulators serving many African countries Became an OIE Collaborating Center in 2013 Demonstrated success in providing controls for the quality of vaccines in Africa Demonstrates what is possible through collaboration and support

9 Session 3: Market Access and Mutual Recognition What is needed – industry’s perspective –Predictability of registration process –Reliability – consistent criteria –Simplified process – no repetition / unnecessary administrative burden –Appropriate enforcement mechanisms by authorities –Regional oversight of manufacturing sites –Recognition of and alignment with appropriate international standards in relation to manufacturing and control procedures 9

10 Session 3: Market Access and Mutual Recognition EXAMPLE: GALVmed The value of mutual recognition procedures was noted and realized for veterinary vaccines in East Africa. Has the following advantages: –Accelerates the availability of quality vaccines –Avoids duplication –Improves predictability –Builds trust between regulators –Allows rapid introduction of vaccines against new diseases

11 Session 3: What can hinder or limit Market Access and Mutual Recognition? Limiting factors to market access and mutual recognition –Not respecting WTO rules –Inadequate VMP market control –Lack of harmonization –Lack of acceptance of new technologies –Retroactive action on existing products –Poor control over counterfeit products –Data protection – confidentiality –Lack of visibility of changes in regulatory environment –Unreasonable registration costs 11

12 Session 4: Regional Organizations What can Regional Organizations provide? –Harmonization - harmonized technical requirements in line with intergovernmental standards –Flexibility - organizational and procedural - for marketing authorizations –Adaptability - regional solutions that can be adapted to local situations Examples – VICH, EU, South African, Asian, South American, US-Canada models

13 Session 4: What is needed for Regional Organizations to work? Characteristics, Benefits and Needs of Regional Organizations –Need for technical and regulatory commitment –Legal basis for mutual recognition –Structure to bring regulators and industry together on a regular basis –Time to build trusting and sustainable relationships –Confidentiality and transparency –Networking –Inclusivity of process –Common language

14 Breakout Sessions KEY THEMES common across Sessions Must have political will among government departments Must have good governance May need capacity building Need adequate resources Communication is a must Trust among regulators and industry

15 Breakout Sessions KEY THEMES common across Sessions Need for strengthening professional organizations and ethical standards Improved marketing infrastructure Ensure confidentiality of data Build capacity of leaders in the field, end users, professionals Human and veterinary single agencies should work together so not to compete for resources 15

16 Breakout Sessions KEY THEMES common across Sessions International norms are advantageous - with caveats Regular joint review of guidelines Convergence offers potential for Increased pharmacovigilance Increased monitoring of resistance Increased access to products

17 Breakout Sessions KEY THEMES common across Sessions What are some perceived potential disadvantages of regulatory convergence? –Loss of flexibility to make local decisions and standards –Loss of market to local industry –Need time to develop processes –Capacity building requires financial, IT, and training resources 17

18 Pre-Conference VICH Workshop June 24, 2015 Introduction to VICH Role of VICH Guidelines in the product registration process Introduction to VICH Outreach Forum How to get involved in VICH How to get more information 18

19